Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Paola Barsotti is active.

Publication


Featured researches published by Paola Barsotti.


The New England Journal of Medicine | 1984

Effects of sulindac and ibuprofen in patients with chronic glomerular disease. Evidence for the dependence of renal function on prostacyclin.

Giovanni Ciabattoni; Giulio A. Cinotti; Alessandro Pierucci; Bianca M. Simonetti; Massimo Manzi; Francesco Pugliese; Paola Barsotti; Gabriella Pecci; Franco Taggi; Carlo Patrono

We investigated whether the glomerular synthesis of prostacyclin modulates the renal blood flow and glomerular filtration rate in chronic glomerular disease. The urinary excretion of 6-keto-prostaglandin F1 alpha, a stable breakdown product of prostacyclin, was significantly (P less than 0.01) reduced in 20 women with chronic glomerular disease, as compared with 19 controls, whereas excretion of urinary prostaglandin E2 was unchanged. In 10 patients randomly assigned to one week of treatment with ibuprofen, excretion of urinary 6-keto-prostaglandin F1 alpha and prostaglandin E2 was reduced by 80 per cent, the level of serum creatinine was increased by 40 per cent, and creatinine and para-aminohippurate clearances were reduced by 28 and 35 per cent, respectively. The reduction of both clearances was inversely related (P less than 0.01) to the basal urinary excretion of 6-keto-prostaglandin F1 alpha but not of prostaglandin E2. No functional changes were detected in five healthy women, despite a similar suppression of renal prostacyclin synthesis by ibuprofen. In contrast, one week of treatment with sulindac did not affect renal prostacyclin synthesis or renal function in the other 10 patients, despite a marked inhibition of extrarenal cyclooxygenase activity. We conclude that in patients with mild impairment of renal function, the renal blood flow and glomerular filtration rate are critically dependent on prostacyclin production. In such patients sulindac may be a safe substitute for other nonsteroidal antiinflammatory drugs.


The FASEB Journal | 2001

Accelerated diabetic glomerulopathy in galectin-3/AGE receptor 3 knockout mice

Giuseppe Pugliese; Flavia Pricci; Carla Iacobini; Gaetano Leto; Lorena Amadio; Paola Barsotti; Luciano G. Frigeri; Dan K. Hsu; Helen Vlassara; Fu Tong Liu; Umberto Di Mario

Several molecules were shown to bind advanced glycation end products (AGEs) in vitro, but it is not known whether they all serve as AGE receptors and which functional role they play in vivo. We investigated the role of galectin‐3, a multifunctional lectin with (anti)adhesive and growth‐regulating properties, as an AGE receptor and its contribution to the development of diabetic glomerular disease, using a knockout mouse model. Galectin‐3 knockout mice obtained by gene ablation and the corresponding wild‐type mice were rendered diabetic with streptozotocin and killed 4 months later, together with age‐matched nondiabetic controls. Despite a comparable degree of metabolic derangement, galectin‐3‐deficient mice developed ac‐celerated glomerulopathy vs. the wild‐type animals, as evidenced by the more pronounced increase in protein‐uria, extracellular matrix gene expression, and mesan‐gial expansion. This was associated with a more marked renal/glomerular AGE accumulation, indicating it was attributable to the lack of galectin‐3 AGE receptor function. The galectin‐3‐deficient genotype was associated with reduced expression of receptors implicated in AGE removal (macrophage scavenger receptor A and AGE‐R1) and increased expression of those mediating cell activation (RAGE and AGE‐R2). These results show that the galectin‐3‐regulated AGE receptor pathway is operating in vivo and protects toward AGE‐induced tissue injury in contrast to that through RAGE.—Pugliese, G., Pricci, F., Iacobini, C., Leto, G., Amadio, L., Barsotti, P., Frigeri L., Hsu, D. K., Vlassara, H., Liu, F.‐T., Di Mario, U. Accelerated diabetic glomerulopathy in galectin‐3/AGE receptor 3 knockout mice. FASEB J. 15, 2471–2479 (2001)


Veterinary Parasitology | 2002

Feline leishmaniosis due to Leishmania infantum in Italy

Alessandro Poli; Francesca Abramo; Paola Barsotti; Stefano Leva; Marina Gramiccia; Alessandra Ludovisi; Francesca Mancianti

A case of leishmaniosis in domestic cats (Felis catus domesticus) is described. The subject showed a nodular lesion on the eyelid. The diagnosis was achieved by serological, parasitological, and light and electron microscopic investigations. By molecular techniques the aetiological agent was identified as belonging to Leishmania infantum, the species implicated in human and canine leishmaniosis in southern Europe. A preliminary study on the prevalence of asymptomatic feline leishmaniosis, performed in the areas where the infected cat was identified, revealed a low seroprevalence of infection: only 1 (0.9%) of the 110 cat sera examined by indirect fluorescent antibody test was positive for anti-Leishmania antibodies. Because clinical signs in feline leishmaniosis are unspecific and similar to those observed in other diseases commonly found in this species, leishmaniosis must be added to the differential diagnosis by feline veterinary practitioners and adequate serologic and histopathologic investigations must be performed in endemic areas.


Journal of The American Society of Nephrology | 2003

Role of Galectin-3 in Diabetic Nephropathy

Carla Iacobini; Lorena Amadio; Giovanna Oddi; Carlo Ricci; Paola Barsotti; Serena Missori; Mariella Sorcini; Umberto Di Mario; Flavia Pricci; Giuseppe Pugliese

The advanced glycosylation end products (AGE) participate in the pathogenesis of nephropathy and other diabetic complications through several mechanisms, including their binding to cell surface receptors. The AGE receptors include RAGE, the macrophage scavenger receptors, OST-48 (AGE-R1), 80K-H (AGE-R2), and galectin-3 (AGE-R3). Galectin-3 interacts with the beta-galactoside residues of cell surface and matrix glycoproteins via the carbohydrate recognition domain and with intracellular proteins via peptide-peptide associations mediated by its N-terminus domain. These structural properties enable galectin-3 to exert multiple functions, including the mRNA splicing activity, the control of cell cycle, the regulation of cell adhesion, the modulation of allergic reactions, and the binding of AGE. The lack of transmembrane anchor sequence or signal peptide suggests that it is associated with other AGE receptors, possibly AGE-R1 and AGE-R2, to form an AGE-receptor complex, rather than playing an independent role. In target tissues of diabetic vascular complications, such as the endothelium and mesangium, galectin-3 is weakly expressed under basal conditions and is markedly upregulated by the diabetic milieu (and to a lesser extent by aging). Galectin-3-deficient mice were found to develop accelerated diabetic glomerulopathy versus the wild-type animals, as evidenced by the more pronounced increase in proteinuria, mesangial expansion, and matrix gene expression. This was associated with a more marked renal/glomerular AGE accumulation, suggesting that it was attributable to the lack of galectin-3 AGE-receptor function. These data indicate that galectin-3 is upregulated under diabetic conditions and is operating in vivo to provide protection toward AGE-induced tissue injury, as opposed to RAGE.


Pediatric Nephrology | 1999

Delayed onset of systemic lupus erythematosus in patients with "full-house" nephropathy.

Alessandra Gianviti; Paola Barsotti; V. Barbera; Tullio Faraggiana; Gianfranco Rizzoni

Abstract Three patients are described who presented with a glomerulopathy suggestive of lupus nephritis in the absence of other clinical and biological evidence of systemic lupus erythematosus (SLE). Renal biopsies showed a ”full-house” immunofluorescence pattern and two patients also had cytoplasmic tubuloreticular inclusions by electron microscopy. All these patients developed antinuclear and anti-double-stranded DNA antibodies 3, 5, and 10 years after their original presentation. Subsequently, 1 patient also developed clinical symptoms of lupus. Reviewing all renal biopsies performed in our department, we found 14 additional patients who presented with a ”full-house” immunofluorescence glomerulonephritis in the absence of other features of SLE. After a mean follow-up of 5.8 years, these patients have not developed serological or clinical evidence of SLE. We conclude that a ”full-house” glomerulopathy in children may be the first symptom of SLE, especially when cytoplasmic tubuloreticular inclusions are detected. The appearance of other clinical and biological symptoms may be delayed by several years.


Pediatric Nephrology | 2001

Kidney transplantation in a girl with methylmalonic acidemia and end stage renal failure.

R. Lubrano; P. Scoppi; Paola Barsotti; E. Travasso; S. Scateni; S. Cristaldi; M. A. Castello

Abstract. Methylmalonic acidemia (MMA) is an inborn error of organic acid metabolism that occurs in infancy with hypotonia, vomiting, dehydration, lethargy and failure to thrive and is biochemically characterized by metabolic ketoacidosis, hyperammonemia and sometimes hyperglycinemia. It results from deficiency of methylmalonyl-CoA mutase activity due to a defect in the mutase apoenzyme or to deficient function of one of the enzymes required for metabolism of its cofactor vitamin B12. Tubulointerstitial nephritis with progressive impairment of renal function is one of the most frequent long-term complications. We describe a case of a 17-year-old girl with methylmalonic acidemia unresponsive to vitamin B12 therapy. The clinical symptoms appeared at 4 months of life. She progressed into end stage renal disease and in January 1996 she started on hemodialytic treatment. In November 1996 we performed a kidney transplant. At present, urinary excretion of methylmalonic acid is normal and the renal function of the transplanted kidney is normal without any rejection episodes. We think that a kidney transplant could be a good therapeutic choice for the metabolic alterations in MMA with end stage renal disease. Indeed it would seem that the small methylmalonyl-CoA mutase activity present in the transplanted kidney could be sufficient to ensure normal metabolism of organic acids. Otherwise, the therapeutic goal can be achieved with a protein-restricted diet.


Pediatric Nephrology | 1994

Acute tubulointerstitial nephritis occurring with 1-year lapse in identical twins

Alessandra Gianviti; Marcella Greco; Paola Barsotti; Gianfranco Rizzoni

We report monozygotic female twins who developed acute tubulointerstitial nephritis, with identical histological features and similar clinical symptoms, 1 year apart. Both patients presented with acute renal failure; only one developed bilateral uveitis after the onset of the nephritis.


Virchows Archiv B Cell Pathology Including Molecular Pathology | 1986

Immunoreactivity for S-100 protein in dendritic and in lymphocyte-like cells in human lymphoid tissues*

Stefania Uccini; Domenico Vitolo; Antonella Stoppacciaro; Donatella Paliotta; Anna Maria Cassano; Paola Barsotti; Luigi Ruco; Carlo D. Baroni

SummaryS-100 protein is an immunohistochemical marker for a subset of dendritic cells, the interdigitating reticulum cells (IDRCs), which are mainly located in T-dependent areas of lymphoid tissues. In the present study we have investigated the distribution of S-100-positive cells in lymph nodes, spleen, thymus and peripheral blood of normal subjects. Immunoreactivity for S-100 protein was demonstrated in large cells with dendritic morphology and in small lymphocyte-like cells present in the lymph node paracortex, thymic medulla, splenic periarterial lymphatic sheaths (PALS) and in peripheral blood. S-100-positive lymphocyte-like cells were frequently detected around high endothelial venules (HEV) and were present in numbers comparable to those of S-100-positive IDRCs. Immunoelectron microscopy confirmed the existence of positive cells with lymphoid morphology and revealed that the intracellular distribution of the immunoreaction product was similar in lymphoid and dendritic cells. Further characterization of S-100-positive cells demonstrated that both lymphoid and dendritic cells were unreactive with a large panel of monocytic and macrophage markers.


Histopathology | 1987

B- and T-cell non-Hodgkin's lymphomas with large multilobated cells: morphological, phenotypic and clinical heterogeneity.

Carlo D. Baroni; Edoardo Pescarmona; A. Calogero; A.M. Cassano; F. Pezzella; Paola Barsotti; A. Gallo; Luigi Ruco

Ten cases of non‐Hodgkins lymphomas, mainly composed of large multilobated cells, have been studied. Our results are consistent with the view that they represent a somewhat heterogeneous group of lymphoid tumours displaying different morphological, clinical and immunophenotypic features. In B‐cell type the large multilobated cells were histologically characterized by prominent nucleoli and distinctly basophilic cytoplasm whereas in the T‐cell type they had indistinct or small nucleoli and ill‐defined weakly eosinophilic cytoplasm. These difterential features between B‐ and T‐cell type were confirmed by electron microscopy. From a clinical standpoint B‐cell type was characterized by a constant involvement of lymphoid tissues (lymph nodes and/or Waldeyers ring); T‐cell type showed, on the contrary, a more frequent involvement of extra‐lymphoid sites (mainly bone and subcutaneous tissues). Our study provides some morphological features that may be helpful for a correct differential diagnosis in this heterogeneous group of non‐Hodgkins lymphomas.


Veterinary Immunology and Immunopathology | 1995

Renal involvement in Feline Immunodeficiency Virus infection: p24 antigen detection, virus isolation and PCR analysis

Alessandro Poli; Francesca Abramo; Donatella Matteucci; Fulvia Baldinotti; Mauro Pistello; S Lombardi; Paola Barsotti; Mauro Bendinelli

Renal alterations characterized morphologically by glomerular and tubulo-interstitial lesions and clinically by a heavy proteinuria and sometimes by renal failure are frequent in feline immunodeficiency virus (FIV) infected cats. To investigate the possible role of local FIV replication in the genesis of this renal damage, renal tissues of 15 consecutive naturally infected and five non-infected cats were examined for traces of the virus by immunohistochemistry, using a monoclonal anti-p24 antibody in a streptavidin-biotin peroxidase labeled system, cultivation and polymerase chain reaction (PCR). Tubular epithelial cells as well as scattered interstitial inflammatory and glomerular cells were positive for p24 antigen in 13 cats. Viral isolation was successful in seven cats, and FIV gag DNA and RNA sequences were detected in 14 and five cats, respectively. Control cats were constantly negative. Although not conclusive, these results suggest that a direct role of FIV in the induction of the renal damage observed in infected animals is possible.

Collaboration


Dive into the Paola Barsotti's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Luigi Ruco

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Tullio Faraggiana

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar

Andrea Onetti Muda

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar

Anna Maria Cassano

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar

Carla Iacobini

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar

Carlo D. Baroni

Sapienza University of Rome

View shared research outputs
Researchain Logo
Decentralizing Knowledge